iBio (IBIO) Equity Ratio (2016 - 2025)

iBio (IBIO) has disclosed Equity Ratio for 15 consecutive years, with 0.88 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 37.16% to 0.88 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.88 through Dec 2025, up 37.16% year-over-year, with the annual reading at 0.64 for FY2025, 13.52% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.88 at iBio, up from 0.87 in the prior quarter.
  • The five-year high for Equity Ratio was 0.88 in Q4 2025, with the low at 0.27 in Q4 2023.
  • Average Equity Ratio over 5 years is 0.61, with a median of 0.64 recorded in 2024.
  • The sharpest move saw Equity Ratio soared 683.83% in 2021, then tumbled 49.28% in 2022.
  • Over 5 years, Equity Ratio stood at 0.72 in 2021, then crashed by 49.28% to 0.36 in 2022, then fell by 25.61% to 0.27 in 2023, then surged by 136.9% to 0.64 in 2024, then soared by 37.16% to 0.88 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.88, 0.87, and 0.64 for Q4 2025, Q3 2025, and Q2 2025 respectively.